Bendamustine in heavily pre-treated multiple myeloma patients: Results of a retrospective analysis from the Korean Multiple Myeloma Working Party

BACKGROUND: Bendamustine may be a potential treatment option for patients with myeloma, but little is known about the utility of bendamustine as a salvage treatment, especially in Asian patients. METHODS: We performed a multicenter retrospective study of patients with relapsed or refractory myeloma...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Seok Jin, Bang, Soo-Mee, Choi, Yoon Seok, Jo, Deog-Yeon, Kim, Jin Seok, Lee, Hyewon, Eom, Hyeon Seok, Yoon, Dok Hyun, Suh, Cheolwon, Lee, Je-Jung, Hong, Junshik, Lee, Jae Hoon, Koh, Youngil, Kim, Kihyun, Yoon, Sung-Soo, Min, Chang-Ki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5054252/
https://www.ncbi.nlm.nih.gov/pubmed/27722131
http://dx.doi.org/10.5045/br.2016.51.3.193

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5054252/
https://www.ncbi.nlm.nih.gov/pubmed/27722131
http://dx.doi.org/10.5045/br.2016.51.3.193

Ejemplares similares